Nabilone for Healthy Individuals
(NABI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests nabilone, a substance similar to cannabis, to observe its effects on a brain enzyme called FAAH. Researchers will use brain scans to determine if nabilone alters FAAH levels and whether these changes relate to treatment response. The study seeks healthy individuals who can complete a week-long course of nabilone, gradually increasing to a 2mg dose. Participants should not have serious medical conditions or a history of mental health issues. As a Phase 4 trial, this research aims to understand how the already FDA-approved and effective treatment benefits more patients.
Will I have to stop taking my current medications?
You may need to stop taking certain medications that interact with nabilone, such as diazepam, sodium secobarbital, alcohol, codeine, or any medications that affect mental or physical function. The trial does not specify a washout period, but it's important to discuss your current medications with the study team.
What is the safety track record for nabilone?
Research has shown that nabilone has been tested and used to treat nausea and vomiting in cancer patients, indicating it is generally well-tolerated in humans. Some people may feel sleepy or lightheaded, as reports show that drowsiness or dizziness can occur.
Nabilone is a Schedule II drug, meaning it carries a risk of dependency or abuse, so it should be used carefully. Mixing nabilone with alcohol or other substances that affect the mind can lead to unwanted effects.
People with severe liver problems or certain emotional disorders should exercise extra caution. Overall, nabilone has a history of safe use, but awareness of these potential side effects is important.12345Why are researchers enthusiastic about this study treatment?
Nabilone is unique because it is a synthetic cannabinoid that mimics the effects of THC, the active compound in cannabis. Unlike traditional treatments that might not target the same pathways, Nabilone interacts with the body's endocannabinoid system, potentially offering different benefits. Researchers are excited about its potential to provide relief with fewer side effects compared to some conventional medications. Additionally, its ability to be carefully dosed over a short period allows researchers to quickly assess its impact on patients, setting it apart from treatments that might take longer to evaluate.
What is the effectiveness track record for nabilone?
Research has shown that nabilone, a substance similar to cannabis, may help with several conditions. For people with posttraumatic stress disorder (PTSD), nabilone helps them sleep longer and reduces nightmares. It has also been somewhat effective in treating long-term pain and nausea. In another study, nabilone improved headaches and the quality of life for people who overuse headache medication. While results can differ, nabilone shows promise in these areas. This trial will investigate how nabilone might affect brain enzyme levels in healthy individuals.678910
Who Is on the Research Team?
Isabelle Boileau, PhD
Principal Investigator
Centre for Addiction and Mental Health
Stefan Kloiber, MD
Principal Investigator
Centre for Addiction and Mental Health
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 19-65 who can handle a week-long course of nabilone, a cannabis-like substance. Participants must be able to provide ID for age verification, sign informed consent, and commit to completing the study activities including interviews and brain scans.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Imaging
Participants undergo baseline MRI and PET scans to assess initial FAAH levels
Treatment
Participants receive a 1-week titrated dose of nabilone, starting at 0.25 mg and increasing to 2 mg
Post-Treatment Imaging
Participants undergo follow-up PET scans to assess changes in FAAH levels after nabilone treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment, including mood and drug-related assessments
What Are the Treatments Tested in This Trial?
Interventions
- Nabilone
Trial Overview
The study tests how nabilone affects an enzyme in the brain related to endocannabinoids using MRI and PET scans. It aims to determine if nabilone lowers this enzyme's levels and if such changes correlate with how participants respond clinically to the drug.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will be prescribed a 1 week daily oral dose of nabilone which will begin at 0.25 mg and work their way up to 2 mg over the course of 7 days.
Nabilone is already approved in United States, Canada, United Kingdom for the following indications:
- Chemotherapy-induced nausea and vomiting
- Chemotherapy-induced nausea and vomiting
- Chemotherapy-induced nausea and vomiting
Find a Clinic Near You
Who Is Running the Clinical Trial?
Centre for Addiction and Mental Health
Lead Sponsor
Citations
Nabilone for Chronic Pain Management: A Review of ... - NCBI
Mixed results from two RCTS of FMS patients, one reported nabilone led to pain relief (n=40) and the other reported nabilone did not reduce ...
Long-term safety and efficacy of open-label nabilone on ...
Clinical trial data from other cohorts suggests that nabilone improves nightmares and sleep duration in posttraumatic stress disorder as well as ...
Nabilone for the treatment of medication overuse headache
This is the first randomized controlled trial demonstrating the benefits of nabilone on headache, analgesic consumption and the quality of life in patients ...
4.
sciencedirect.com
sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/nabiloneNabilone - an overview | ScienceDirect Topics
Laboratory studies and clinical reports suggest that nabilone has moderate efficacy in the treatment of nausea, chronic pain, pain-associated insomnia, PTSD- ...
Safety and Efficacy of Nabilone in Alzheimer's Disease
Nabilone is a new class of medication that may be a safe and effective treatment for agitation in AD, with added benefits on appetite and pain. Reducing these ...
Cesamet® (nabilone) Capsules DESCRIPTION
Cesamet was evaluated for its effectiveness and safety in the treatment of nausea and vomiting induced by cancer chemotherapy in patients receiving a wide ...
7.
sigmaaldrich.com
sigmaaldrich.com/US/en/sds/sigma/n3785?srsltid=AfmBOoq7SyQAkacgiUFWuYYBXWhsiS-HTOlKXIhEC1LUfSmYSNdSJh3P• SAFETY DATA SHEET
May cause drowsiness or dizziness. Specific target organ toxicity - repeated exposure. No data available. Aspiration hazard. No data available ...
Nabilone - LiverTox - NCBI Bookshelf - NIH
Nabilone is classified as a Schedule II drug, indicating that it has clear potential for physical and psychological dependency and abuse.
N ACT NABILONE
ACT NABILONE should not be taken with alcohol, sedatives, hypnotics, or other psychotomimetic substances. ACT NABILONE should not be used ...
Consumer Information for: ACT NABILONE
ACT NABILONE should be used with extreme caution if you have severe liver dysfunction or a history of nonpsychotic emotional disorders.
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.